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Cases of Yersinia pseudotuberculosis infection in-
creased in France during the winter of 2004–05 in the ab-
sence of epidemiologic links between patients or strains. 
This increase represents transient ampliﬁ  cation of a patho-
gen endemic to the area and may be related to increased 
prevalence of the pathogen in rodent reservoirs.
Y
ersinia pseudotuberculosis is an enterobacterial patho-
gen able to grow at low temperatures. It is widespread 
in the environment (e.g., water, plants), which is the source 
of contamination for mammals (especially rodents and their 
predators) and birds (1,2). Although most cases of human 
infection are sporadic, outbreaks have occurred in Japan 
(3,4), Russia (5,6), and Finland (7,8), mainly associated 
with unchlorinated drinking water or contaminated veg-
etables. In France, similar increases in case numbers had 
not been noted until the winter of 2004–05.
The Study
In early January 2005, the French Yersinia National 
Reference Laboratory (YNRL) received 3 Y. pseudotu-
berculosis strains isolated by the same laboratory in Dijon 
over a 1-week period: 2 from fecal samples of 2 children 
attending the same daycare center and 1 from the blood 
of a 65-year-old woman. During the same month, 8 addi-
tional strains were isolated from persons in other parts of 
the country by the Yersinia Surveillance Network (based 
on voluntary participation of 88 hospital-based and private-
sector medical laboratories throughout France). 
In view of this unusually high number of Y. pseudotu-
berculosis isolations over a short period, the YNRL alerted 
France’s national disease surveillance network, the Institut 
de Veille Sanitaire, which thereafter performed an epide-
miologic investigation. In early February, a request was 
mailed to all member laboratories in the Yersinia Surveil-
lance Network and all 95 microbiology laboratories in uni-
versity medical centers, asking them to report any recent 
cases of Y. pseudotuberculosis infection. A reminder letter 
was mailed to all laboratories that had not replied within 
1 month of the initial communication. Moreover, from 
February through April 2005, a total of 76 general medical 
center laboratories were contacted by telephone and asked 
to provide the YNRL with any relevant information and/or 
isolates. Overall, 27 cases of culture-conﬁ  rmed Y. pseudo-
tuberculosis infections were spontaneously reported or ac-
tively retrieved (Table 1).
Case reports of Y. pseudotuberculosis infection peaked 
in January 2005. A food-exposure analysis for the ﬁ  rst 10 
patients did not identify a potential common food source, so 
a food survey was not performed for subsequent cases. The 
pseudotuberculosis cases occurred in 19 different counties 
throughout France, not necessarily the most populated ones 
(Figure 1). Data on lifestyle and living conditions were 
obtained for all but 7 patients, of whom 3 had died and 
4 (including 2 children) were lost to follow-up. Of the 22 
adults, 13 lived in small towns (<5,000 inhabitants) and 5 
lived in rural villages (<500 inhabitants). All but 4 lived in 
houses, as opposed to apartments. Of the 17 adults whose 
lifestyle was investigated in detail, 14 had a dog, hunted, 
gardened, and/or grew their own vegetables. In contrast, 
all 5 children lived in urban areas (>50,000 inhabitants), 
compared with only 3 of the 22 adults; 4 of the children 
lived in apartments.
Of the 27 strains isolated, 25 were sent to the YNRL 
for characterization. All but 4 strains belonged to serotype I, 
the most common serotype in France. Pulsed-ﬁ  eld gel elec-
trophoresis after SpeI digestion of genomic DNA showed 
that (with the exception of the isolates from the 2 children 
attending the same daycare center) the DNA ﬁ  ngerprints 
of the 16 other isolates sent to the YNRL during the peak 
period were all distinct, even when the strains were isolated 
from the same county (data not shown).
Conclusions
This episode of increased case numbers differs from 
episodes reported in the literature by the nationwide distri-
bution of cases, the absence of a locally deﬁ  ned cluster, the 
genetic diversity of the isolates, the predominance of rural 
residence for patients, and the dominant clinical presenta-
tion of septicemia (3–8). Because the cases were not related 
to the consumption of a food product sold nationally (e.g., 
by a supermarket chain), the unknown origin of this phe-
nomenon raises the question of an emerging risk in a new 
epidemiologic situation.
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DOI: 10.3201/eid1407.071339 Of the 27 patients, 19 lived in a strip of land that stretch-
es from northern France to the Atlantic coast and corre-
sponds to the ﬂ  yways of small migratory birds. Hence, the 
avian introduction of strains into the country would have 
been a possible scenario, as has already been suspected for 
an epizootic of pseudotuberculosis in an American wildlife 
park (9). Indeed, during the winter of 2004–05, France wit-
nessed a large and unexpected invasion of Bohemian wax-
wings (Bombycilla garrulus) (10), a species known to mi-
grate from circumpolar areas where pseudotuberculosis is 
endemic. At that same time, 3 pseudotuberculosis outbreaks 
were reported in Siberia (11). However, the genetic diversity 
of the strains isolated from the patients in France and the 
absence of PCR ampliﬁ  cation of the superantigen-encoding 
gene ypm gene (12) (which is highly prevalent in Far Eastern 
strains [1]) do not support bird-borne arrival in France of a Y. 
pseudotuberculosis clone from Russia or the Far East.
These cases occurred in areas where other human 
cases of Y. pseudotuberculosis septicemia had been di-
agnosed (albeit at a much lower rate) in the past 16 years 
(Figure 2). Exacerbation of a preexisting epidemiologic 
situation is quite likely. Most previous cases of Y. pseudo-
tuberculosis septicemia also concerned inhabitants of low-
altitude plains (Figure 2), mainly in rural areas with exten-
sive agriculture zones, which provide favorable habitats for 
small mammals. Cases were frequently (27.1%) reported 
in 5 central-western counties of France, where just 4.6% of 
the population live and incidence of Francisella tularensis 
infection (tularemia) is high (27.3%) (www.invs.sante.fr/
surveillance/tularemie/donnees.htm). Moreover, 40 cases 
of tularemia (with incidence peaks in summer and autumn) 
were reported to the national surveillance system in 2004 
(notiﬁ  cation of the disease has been obligatory since 2002), 
whereas only 8 to 19 cases per year had been reported over 
the preceding and following periods. Like Y. pseudotuber-
culosis, F. tularensis is known to have a rodent reservoir. 
Hence, the spatial and temporal correlations between hu-
man tularemia and pseudotuberculosis in France over re-
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Table 1. Relevant characteristics of 27 patients with Yersinia pseudotuberculosis infection, France, winter 2004–05* 
Age, y  Sex Risk factors  Main clinical signs/symptoms 
Site of organism 
isolation O serotype 
Illness
outcome
0.8 M None Diarrhea Feces I Recovery 
1 M None Diarrhea Feces III Recovery 
2 F None Diarrhea Feces I Recovery 
6 M None Diarrhea Feces I Recovery 
9 F None Diarrhea Feces I Recovery 
17 M Multiple injuries (motorcycle 
accident)
Postsurgical infection†  Blood I Recovery 
36 F HIV infection  Diarrhea, mesenteric adenitis  Feces I Recovery 
44 F Bone marrow transplantation  Fever Blood I Death
51 F Sickle cell anemia, cirrhosis Diarrhea, esophageal variceal 
bleeding
Blood I Death
59 M Cirrhosis Fever, esophageal variceal 
bleeding
Blood I Recovery 
61 M Therapeutic aplasia (colorectal 
cancer)
Fever, abdominal pain  Blood I Death
64 M Abdominal aortic aneurysm  Abdominal pain  Artery biopsy  I Recovery 
65 F Myeloma  Fever, septic shock  Blood I Death
70 M Cirrhosis Fever Blood I Recovery 
71 M Unknown  Abdominal pain  Blood NA strain  Recovery 
71 M Diabetes, steroid receipt (for 
retroperitoneal fibrosis) 
Fever, diabetes 
decompensation
Blood I Recovery 
72 M Kidney transplantation  Fever Blood I Recovery 
74 M Diabetes Fever, abdominal pain  Blood NS Recovery 
75 M Viral hepatitis C infection  Fever Blood I Recovery 
76 M Cirrhosis Fever Blood NS Recovery 
78 M Calcific aortic stenosis  Fever, acute heart failure  Blood I Recovery 
78 M Diabetes Fever, septic shock  Blood and artery 
biopsy 
I Death
79 M Metastatic colorectal cancer  Fever, respiratory distress 
syndrome 
Blood I Death
80 M Cerebrovascular accident  Fever, cardiogenic shock  Blood NA strain  Recovery 
81 F Cirrhosis Fever Blood I Recovery 
82 M Diabetes Fever, septic shock  Blood NA strain  Death
83 M Diabetes Fever Blood I Recovery 
*NA, nonagglutinable; NS, not sent to Yersinia National Reference Laboratory. 
 †This patient’s signs/symptoms began after hospitalization; all other patients’ signs/symptoms began before hospitalization.  Pseudotuberculosis in Humans, France, 2004–05
cent years suggest the sudden expansion of a common res-
ervoir in 2004.
Our analysis of the temporal distribution of human Y. 
pseudotuberculosis septicemia cases over the past 16 years 
showed a peak every 5 years (Table 2). This ﬁ  nding is rem-
iniscent of human hantavirus infections, which have been 
linked to cyclical oscillations in the vole population (the 
virus reservoir). Taken as a whole, these data suggest that a 
rodent reservoir, mainly in rural areas, could have suddenly 
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Figure 1. Map of France, showing spatial distribution of Yersinia 
pseudotuberculosis infections during the winter of 2004–05. 
Black circles, patients’ residences; open circles, cities with 
medical laboratories that stated that they had not isolated any Y. 
pseudotuberculosis from clinical specimens. 
Figure 2. County distribution, France, of Yersinia pseudotuberculosis 
isolated from human blood and reported to the Yersinia National 
Reference Laboratory over the 16 years preceding the winter of 
2004–05. The number of isolates is represented by proportionally 
sized circles arbitrarily located at the center of the counties.
Table 2. Temporal distribution of receipt ofYersinia pseudotuberculosis blood isolates, France 
Monthly isolates*
Period Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug
Annual
isolates
1988–89 0 0 0 0 1 1 2 1 0 0 1 0 6
1989–90 0 0 1 0 1 2 1 0 1 1 0 0 7
1990–91 0 1 0 0 1 1 0 4 0 0 0 0 7
1991–92 0 0 0 1 0 1 1 0 1 0 0 0 4
1992–93 0 0 0 0 1 1 0 1 0 0 0 0 3
1993–94 0 0 0 0 0 0 3 0 2 0 0 0 5
1994–95 0 0 0 0 1 3 1 2 0 0 0 1 8
1995–96 0 0 0 0 1 0 3 0 0 2 0 1 7
1996–97 0 0 0 0 0 1 0 0 0 0 0 0 1
1997–98 0 0 0 0 2 0 0 0 0 0 0 1 3
1998–99 0 0 0 0 0 0 0 1 0 1 0 0 2
1999–00 0 0 0 1 0 2 1 0 0 2 1 1 8
2000–01 0 0 0 0 1 0 0 1 0 2 0 0 4
2001–02 0 0 1 1 0 0 0 0 1 0 0 0 3
2002–03 0 0 0 0 0 1 1 0 0 0 0 0 2
2003–04 0 0 0 0 0 1 4 1 0 2 0 0 8
2004–05† 0 0 0 0 4 4 5 5 0 0 0 0 18
2005–06 0 0 0 0 0 2 2 0 0 0 0 0 4
1988–
2006‡
01
(0.06)§
2
(0.12)
3
(0.18)
9
(0.53)
16
(0.94)
19
(1.12)
11
(0.65)
5
(0.29)
10
(0.59)
2
(0.12)
4
(0.24)
82
(4.82)
*Received by the French Yersinia National Reference Laboratory since September 1988. To encompass the whole cold season, isolates are presented in 
12-month periods from September to August.  
†Period of increased number of cases.  
‡Excludes 2004–05.  
§Numbers in parentheses are mean monthly value over the 17 years in which case numbers were not increased.increased in the spring of 2004, thus increasing the risk for 
human transmission of Y. pseudotuberculosis and F. tular-
ensis over the following months.
Rodent populations tend to increase with ongoing 
changes in agricultural practices, e.g., removal of farmland 
hedges (which provide shelter for the rodents’ predators) 
and reduction in pesticide use. Hence, the dynamics of the 
wild rodent population and reduction in pesticide use may 
represent a useful predictive marker for the occurrence of 
new outbreaks. The surveillance and control of the small 
mammal population might help limit the incidence of 
pseudotuberculosis and other wild rodent–borne diseases 
of humans in France.
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